Literature DB >> 22265837

Synthesis, characterization and chemoprotective activity of polyoxovanadates against DNA alkylation.

Giovana G Nunes1, Ana C Bonatto, Carla G de Albuquerque, Andersson Barison, Ronny R Ribeiro, Davi F Back, André Vitor C Andrade, Eduardo L de Sá, Fábio de O Pedrosa, Jaísa F Soares, Emanuel M de Souza.   

Abstract

The alkylation of pUC19 plasmid DNA has been employed as a model reaction for the first studies on chemoprotective action by a mixed-valence (+IV/+V) polyoxovanadate. A new, non-hydrothermal route for the high yield preparation of the test compound is described. The deep green, microcrystalline solid A was isolated after a three-day reaction in water at 80°C and 1 atm, while the reaction at 100°C gave green crystals of B. Both solids were structurally characterized by X-ray diffractometry and FTIR, EPR, NMR and Raman spectroscopies. Product A was identified as (NH(4))(2)V(3)O(8), while B corresponds to the spherical polyoxoanion [V(15)O(36)(Cl)](6-), isolated as the NMe(4)(+) salt. The lack of solubility of A in water and buffers prevented its use in DNA interaction studies, which were then carried out with B. Complex B was also tested for its ability to react with DNA alkylating agents by incubation with diethylsulphate (DES) and dimethylsulphate (DMS) in both the absence and presence of pUC19. For DMS, the best results were obtained with 10 mM of B (48% protection); with DES, this percentage increased to 70%. The direct reaction of B with increasing amounts of DMS in both buffered (PIPES 50 mM) and non-buffered aqueous solutions revealed the sequential formation of several vanadium(IV), vanadium(V) and mixed-valence aggregates of different nuclearities, whose relevance to the DNA-protecting activity is discussed. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22265837     DOI: 10.1016/j.jinorgbio.2011.11.019

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  4 in total

1.  DNA binding, antitumor activities, and hydroxyl radical scavenging properties of novel oxovanadium (IV) complexes with substituted isoniazid.

Authors:  Xiangwen Liao; Jiazheng Lu; Peng Ying; Ping Zhao; Yinliang Bai; Wengjie Li; Mingpei Liu
Journal:  J Biol Inorg Chem       Date:  2013-12       Impact factor: 3.358

2.  Prevention of myelosuppression and genotoxicity induced by cisplatin in murine bone marrow cells: effect of an organovanadium compound vanadium(III)-l-cysteine.

Authors:  Abhishek Basu; Prosenjit Ghosh; Arin Bhattacharjee; Arup Ranjan Patra; Sudin Bhattacharya
Journal:  Mutagenesis       Date:  2015-03-16       Impact factor: 3.000

3.  Polyoxovanadates as new P-glycoprotein inhibitors: insights into the mechanism of inhibition.

Authors:  Diogo Henrique Kita; Gisele Alves de Andrade; Juliana Morais Missina; Kahoana Postal; Viktor Kalbermatter Boell; Francielli Sousa Santana; Ingrid Fatima Zattoni; Isadora da Silva Zanzarini; Vivian Rotuno Moure; Fabiane Gomes de Moraes Rego; Geraldo Picheth; Emanuel Maltempi de Souza; David A Mitchell; Suresh V Ambudkar; Giovana Gioppo Nunes; Glaucio Valdameri
Journal:  FEBS Lett       Date:  2021-12-30       Impact factor: 3.864

4.  Vanadium as a chemoprotectant: effect of vanadium(III)-L-cysteine complex against cyclophosphamide-induced hepatotoxicity and genotoxicity in Swiss albino mice.

Authors:  Abhishek Basu; Arin Bhattacharjee; Somnath Singha Roy; Prosenjit Ghosh; Pramita Chakraborty; Ila Das; Sudin Bhattacharya
Journal:  J Biol Inorg Chem       Date:  2014-04-29       Impact factor: 3.358

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.